Respiratory Aspiration  >>  amikacin inhalation solution (NKTR-061)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
amikacin inhalation solution (NKTR-061) / Nektar Therap
NCT00805168: Inhaled Amikacin Solution (BAY 41-6551) as Adjunctive Therapy in the Treatment of Gram-Negative Pneumonia

Completed
3
461
Japan, Europe, RoW
Amikacin Inhalation Solution (BAY41-6551), Aerosolized Placebo
Bayer, Nektar Therapeutics, Novartis Pharmaceuticals
Pneumonia, Bacterial
04/17
04/17

Download Options